Prolongation of disease-free life: When is the benefit sufficient to warrant the effort of taking a preventive medicine?

Jesper Bo Nielsen; Ivar Sønbø Kristiansen; Subash Thapa

doi:https://doi.org/10.1016/j.ypmed.2021.106867

doi.org/10.1016/j.ypmed.2021.106867

Prolongation of disease-free life: When is the benefit sufficient to warrant the effort of taking a preventive medicine?

Jesper Bo Nielsen

35

,

Ivar Sønbø Kristiansen

37

,

Subash Thapa

9

Preventive Medicine5.10

Volume: 154, Pages: 106867 - 106867

Published: Jan 1, 2022

Abstract

The prolongation of disease-free life (PODL) required by people to be willing to accept an offer of a preventive treatment is unknown. Quantifying the required benefits could guide information and discussions about preventive treatment. In this study, we investigated how large the benefit in prolongation of a disease-free life (PODL) should be for individuals aged 50-80 years to accept a preventive treatment offer. We used a cross-sectional...